Inventor
SAITO TETSUJI
JP25 patents
⚠️ This page may combine multiple inventors who share the name “SAITO TETSUJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CANON KK
12 patentsUS8380043B2Feb 19, 2013
Reproducing apparatus and reproducing method
CANON KK10 citations92
US8620138B2Dec 31, 2013
Reproducing apparatus and reproducing method
CANON KK5 citations83
US8831404B2Sep 9, 2014
Reproducing apparatus and reproducing method
CANON KK3 citations73
US7626954B2Dec 1, 2009
Communication apparatus and control method thereof
CANON KK7 citations73
US10403233B2Sep 3, 2019
Image processing apparatus and image processing method
CANON KK1 citations62
US9247154B2Jan 26, 2016
Reproducing apparatus and reproducing method
CANON KK2 citations62
US11190742B2Nov 30, 2021
Projection apparatus and control method thereof
CANON KK0 citations57
US10389894B2Aug 20, 2019
Image processing apparatus and method, image projection apparatus, printing apparatus, and image printing and projection system
CANON KK0 citations51
US9860454B2Jan 2, 2018
Reproducing apparatus and reproducing method
CANON KK0 citations51
US9661238B2May 23, 2017
Reproducing apparatus and reproducing method
CANON KK0 citations51
US10839758B2Nov 17, 2020
Image display apparatus, image output apparatus, and control methods thereof
CANON KK0 citations41
US10657622B2May 19, 2020
Controlling projected image frame rate in response to determined projection surface curvature
CANON KK0 citations41
ONO PHARMACEUTICAL CO
8 patentsUS7235667B2Jun 26, 2007
N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
ONO PHARMACEUTICAL CO5 citations72
US10196358B2Feb 5, 2019
KCNQ2-5 channel activator
ONO PHARMACEUTICAL CO2 citations69
US9809544B2Nov 7, 2017
KCNQ2-5 channel activator
ONO PHARMACEUTICAL CO2 citations69
US7629369B2Dec 8, 2009
N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
ONO PHARMACEUTICAL CO0 citations51
US10676438B2Jun 9, 2020
KCNQ2-5 channel activator
ONO PHARMACEUTICAL CO0 citations48
US7947697B1May 24, 2011
8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d] pyrazolo[1,5-a]pyrimidine methanesulfonate as a CRF antagonist
ONO PHARMACEUTICAL CO0 citations45
US10519105B2Dec 31, 2019
KCNQ2-5 channel activator
ONO PHARMACEUTICAL CO0 citations38
US10016439B2Jul 10, 2018
Fused imidazole compounds
ONO PHARMACEUTICAL CO0 citations37